Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009

Emerging Infectious Diseases

Volumn 21, Issue 1, 2015, Pages 23-31

  Conger, Nicholas G ^a   Paolino, Kristopher M ^b   Osborn, Erik C ^a   Rusnak, Janice M ^c   Günther, Stephan ^d   Pool, Jane ^a   Rollin, Pierre E ^e   Allan, Patrick F ^a   Schmidt Chanasit, Jonas ^d   Rieger, Toni ^d   Kortepeter, Mark G ^f  

^a LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Force Health Protection   (United States)

^d Bernard Nocht Institute   (Germany)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BILIRUBIN; CIPROFLOXACIN; CREATININE; D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; FUROSEMIDE; GAMMA INTERFERON; GLUCOSE; HYPERTENSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LEVOFLOXACIN; MEROPENEM; NITRIC OXIDE; PANTOPRAZOLE; PLACENTAL GROWTH FACTOR; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1; ANTIVIRUS AGENT;

ACIDOSIS; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BRAIN EDEMA; BRAIN HERNIA; BRONCHOSCOPY; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRIMEAN CONGO HEMORRHAGIC FEVER; DIARRHEA; DISEASE TRANSMISSION; DRUG SUBSTITUTION; ERYTHROCYTE TRANSFUSION; FEVER; GASTROENTERITIS; GINGIVA BLEEDING; HEALTH CARE PERSONNEL; HEMODIALYSIS; HOSPITAL EQUIPMENT; HOSPITAL INFECTION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; HYPOXIA; INFECTION CONTROL; INTUBATION; KIDNEY FAILURE; LUNG HEMORRHAGE; MALE; PATIENT CARE; PLEURA EFFUSION; PROTECTIVE EQUIPMENT; PULSE RATE; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BLEEDING; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UPPER GASTROINTESTINAL BLEEDING; VIRUS LOAD; VOMITING; YOUNG ADULT; CROSS INFECTION; ETHNOLOGY; FATALITY; GERMANY; HEMORRHAGIC FEVER, CRIMEAN; SOLDIER; TRANSMISSION; UNITED STATES;

ANTIVIRAL AGENTS; CROSS INFECTION; FATAL OUTCOME; GERMANY; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; MALE; MILITARY PERSONNEL; RIBAVIRIN; UNITED STATES; YOUNG ADULT;

EID: 84919703684     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2101.141413     Document Type: Article

References (40)

1. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100:159-89. http://dx.doi.org/10.1016/j.antiviral.2013.07.006
2. Erby A. Crimean-Congo hemorrhagic fever virus. In: Dongyou Liu, editor. Manual of security sensitive microbes and toxins. Boca Raton (FL): CRC Press; 2014. p. 37-52.
3. Rusnak JM. Experience with ribavirin for treatment and postexposure prophylaxis of hemorrhagic fever viruses: Crimean Congo hemorrhagic fever, Lassa fever, and hantavirus [cited 2014 Sep 15]. http://www.absa.org/abj/abj/111602Rusnak.pdf
4. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11:S794-800. http://dx.doi.org/10.1093/clinids/11.Supplement_4.S794
5. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-84. http://dx.doi.org/10.3201/eid1008.030928
6. Wölfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis. 2007;13:1097-100. http://dx.doi.org/10.3201/eid1307.070068
7. Lambert AJ, Lanciotti RS. Consensus amplification and novel multiplex sequencing method for S segment species identification of 47 viruses of the Orthobunyavirus, Phlebovirus, and Nairovirus genera of the family Bunyaviridae. J Clin Microbiol. 2009;47:2398-404. http://dx.doi.org/10.1128/JCM.00182-09
8. Olschläger S, Gabriel M, Schmidt-Chanasit J, Meyer M, Osborn E, Conger NG, et al. Complete sequence and phylogenetic characterisation of Crimean-Congo hemorrhagic fever virus from Afghanistan. J Clin Virol. 2011;50:90-2. http://dx.doi.org/10.1016/j.jcv.2010.09.018
9. Centers for Disease Control and Prevention (CDC). Interim guidance for managing patients with suspected viral hemorrhagic fever in US Hospitals; 2005 19 May [cited 2014 Sept 11]. http://www.cdc.gov/HAI/pdfs/bbp/VHFinterimGuidance05_19_05.pdf.
10. World Health Organization. Application for inclusion of ribavirin in the WHO model list of essential medicines [2010 Sep 15]. http://archives.who.int/eml/expcom/expcom15/applications/newmed/ribaravin/ribavirin.pdf
11. Khan AS, Maupin GO, Rollin PE, Noor AM, Shurie HHM, Shalabi AGA, et al. An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg. 1997;57:519-25.
12. Burney MI, Ghafoor A, Saleen M, Webb PA, Casals J. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan, January 1976. Am J Trop Med Hyg. 1980;29:941-7.
13. Amorosa V, MacNeil A, McConnell R, Patel A, Dillon KE, Hamilton K, et al. Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis. 2010;16:1598-600. http://dx.doi.org/10.3201/eid1610.100774
14. Jauréguiberry S, Tattevin P, Tarantola A, Legay F, Tall A, Nabeth P, et al. Imported Crimean-Congo hemorrhagic fever. J Clin Microbiol. 2005;43:4905-7. http://dx.doi.org/10.1128/JCM.43.9.4905-4907.2005
15. Barry M, Russi M, Armstrong L, Geller D, Tesh R, Dembry L, et al. Treatment of a laboratory-acquired Sabia virus infection. N Engl J Med. 1995;333:294-6. http://dx.doi.org/10.1056/NEJM199508033330505
16. Timen A, Koopmans MP, Vossen AC, van Doornum GJ, Gunther S, van den Berkmortel F, et al. Response to imported case of Marburg hemorrhagic fever, the Netherlands. Emerg Infect Dis. 2009;15:1171-5. http://dx.doi.org/10.3201/eid1508.090015
17. World Health Organization. Global alert and response (GAR). Ebola virus disease, West-update. 2014 Jul 27[cited 4 Aug 2014]. http://www.who.int/csr/don/2014_07_27_ebola/en/
18. Bhagat CI, Lewer M, Prins A, Beilby JP. Effects of heating plasma at 56 degrees C for 30 min and at 60 degrees C for 60 min on routine biochemistry analytes. Ann Clin Biochem. 2000;37:802-4. http://dx.doi.org/10.1258/0004563001899997
19. Bodur H, Akinci E, Onguru P, Carhan A, Uyar Y, Tanrici A, et al. Detection of Crimean-Congo hemorrhagic fever virus genome in saliva and urine. Int J Infect Dis. 2010;14:e247-9. http://dx.doi.org/10.1016/j.ijid.2009.04.018
20. Thomas S, Thomson G, Dowall S, Bruce C, Cook N, Easterbrook L,et al. Review of Crimean Congo hemorrhagic fever infection in Kosova in 2008 and 2009: prolonged viremias and virus detected in urine by PCR. Vector Borne Zoonotic Dis. 2012;12:800-4. http://dx.doi.org/10.1089/vbz.2011.0776
21. Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013;100:20-8. http://dx.doi.org/10.1016/j.antiviral.2013.07.007
22. Bodur H, Akinci E, Ascioglu S, Onguru P, Uyar Y. Subclinical infection with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis. 2012;18:640-2. http://dx.doi.org/10.3201/eid1804.111374
23. Ozturk B, Tutuncu E, Kuscu F, Gurbuz Y, Sencan I, Tuzun H. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int J Infect Dis. 2012;16:e89-93. http://dx.doi.org/10.1016/j.ijid.2011.06.005
24. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EI, et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis. 2010;42:516-21. http://dx.doi.org/10.3109/00365540903582418
25. Çevik MA, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374-9. http://dx.doi.org/10.1016/j.ijid.2007.09.010
26. Ozbey SB, Kader C, Erbay A, Ergonul O. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2014;14:300-2. http://dx.doi.org/10.1089/vbz.2013.1421
27. Onguru P, Dagdas S, Bodur H, Yilmaz M, Akinci E, Eren S, et al. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal. 2010;24:163-6. http://dx.doi.org/10.1002/jcla.20383
28. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Avsic-Zupanc T. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol. 2010;17:1086-93. http://dx.doi.org/10.1128/CVI.00530-09
29. Connolly-Andersen AM, Moll G, Andersson C, Akerström S, Karlberg H, Douagi I, et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol. 2011;85:7766-74. http://dx.doi.org/10.1128/JVI.02469-10
30. Weber F, Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zoonosis. Cytokine Growth Factor Rev. 2008;19:395-404. http://dx.doi.org/10.1016/j.cytogfr.2008.11.001
31. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10 and tumor necrosis factor-α in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941-4. http://dx.doi.org/10.1086/500836
32. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006;36:272-6. http://dx.doi.org/10.1016/j.jcv.2006.04.007
33. Ozturk B, Kuscu F, Tutuncu E, Sencan I, Gurbuz Y, Tuzan H. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Clin Virol. 2010;47:115-9. http://dx.doi.org/10.1016/j.jcv.2009.10.015
34. Peyrefitte CN, Perret M, Garcia S, Rodriguez R, Bagnaud A, Lacote S, et al. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J Gen Virol. 2010;91:189-98. http://dx.doi.org/10.1099/vir.0.015701-0
35. Bodur H, Akinci E, Onguru P, Uyar Y, Basturk B, Gozel MG, et al. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis. 2010;14:e704-7. http://dx.doi.org/10.1016/j.ijid.2010.02.2240
36. Bakir M, Bakir S, Sari I, Celik VK, Gozel MG, Engin A. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Med Virol. 2013;85:1794-801. http://dx.doi.org/10.1002/jmv.23666
37. van Paassen J, Bauer MP, Arbous MS, Visser LG, Schmidt-Chanasit J, Schilling S, et al. Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever. Lancet Infect Dis. 2012;12:635-42. http://dx.doi.org/10.1016/S1473-3099(12)70018-X
38. Andersson I, Lundkvist A, Haller O, Mirazimi A. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol. 2006;78:216-22. http://dx.doi.org/10.1002/jmv.20530
39. Andersson I, Karlberg H, Mousari-Jazi M, Martinez-Sobrido L, Wever F, Mirazimi A. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol. 2008;80:1397-404. http://dx.doi.org/10.1002/jmv.21222
40. Oestereich L, Rieger T, Neumann M, Bernreuther C, Lehmann M, Krasemann S, et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl Trop Dis. 2014;8:e2804. http://dx.doi.org/10.1371/journal.pntd.0002804